Judge again thwarts class certification against Takeda, Teva and others

Value Drug has once again failed to provide evidence that certifying a class of purchasers of wholesale gout medication is warranted, a Pennsylvania federal judge has said.

Unlock unlimited access to all Global Competition Review content